Upload

Biology Behind Targeted Therapy for Lymphomas

NCINewsNCINews·50 videos
1,680
702 views
Like     Dislike 0

Sign in to YouTube

Sign in with your YouTube Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like NCINews's video.

Sign in to YouTube

Sign in with your YouTube Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike NCINews's video.

Sign in to YouTube

Sign in with your YouTube Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add NCINews's video to your playlist.

Published on Mar 30, 2012

Louis Staudt, M.D., Ph.D., discusses the basic biology of targeted therapy for Diffuse B-cell Lymphoma. Dr. Staudt talks about how ibrutinib is a very specific agent that has a high degree of efficacy with only modest side effects in treating the ABC form of Diffuse B-cell Lymphoma. More info: http://j.mp/HffUy7

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

All Comments (0)

Sign in now to post a comment!
  • Loading comment...
Loading...
Loading...
Working...
Sign in to add this to a playlist